Last reviewed · How we verify
A Randomized, Double-blind, Placebo-controlled Study of the Use of Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
This is a randomized, double-blind, placebo-controlled study of oral cromolyn sodium when made into a viscous preparation for the treatment of eosinophilic esophagitis.
Details
| Lead sponsor | University of Tennessee |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 16 |
| Start date | 2014-12 |
| Completion | 2017-12 |
Conditions
- Eosinophilic Esophagitis
Interventions
- oral cromolyn sodium
- Placebo
Primary outcomes
- Peak Esophageal Eosinophil Count — 2 months
Measure of the peak esophageal eosinophil count on esophageal biopsy specimens after 2 months of therapy
Countries
United States